A recent study led by researchers from Boston Children’s Hospital, the Department of Pediatrics at Harvard Medical School and several other institutions, concludes that the clinical trials for drugs approved as treatment for so-called ADHD were not designed to assess adverse events or long-term safety and effectiveness.
According to investigative journalist Kelly Patricia O’Meara, researchers identified 32 clinical trials used to obtain approval of ADHD drugs and found the following:
- Eleven drugs (55%) were approved with less than 100 participants.
- The median length of time that the drug was tested prior to its approval was only four weeks.
- 38% of the drugs were actually approved with participants studied less than four weeks.
Drug regulatory agencies in eight countries have issued 44 warnings that ADHD drugs/stimulants cause harmful, even life-threatening side effects, including abnormal heart rate/rhythm, depression, hallucinations, homicidal ideation, insomnia, irritability, hostility, mania/psychosis, seizures, stunted growth, stroke and sudden death. These drug warnings can be accessed through CCHR International’s psychiatric drug side effects search engine.
With no medical tests to prove the existence of ADHD, leading neuroscientists have stated that “ADHD” is no more than a description of behaviors, not a true medical disease requiring drugs to treat it.
WARNING: Anyone wishing to discontinue psychiatric drugs is cautioned to do so only under the supervision of a competent medical doctor because of potentially dangerous withdrawal symptoms.
If you or someone you know has experienced harmful side effects from an ADHD drug, we want to talk to you. You can contact us privately by clicking here or by calling 303-789-5225. All information will be kept in the strictest confidence. We welcome your comments on this article below.